IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES

被引：0
|
作者：
Visentin, R. [1 ]
Schiavon, M. [1 ]
Giegerich, C. [2 ]
Sieber, J. [2 ]
Man, C. Dalla [1 ]
Cobelli, C. [1 ]
Klabunde, T. [2 ]
机构：
[1] Univ Padua, Dept Informat Engn, Padua, Italy
[2] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
037
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [21] Comment on "a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes"
    Freemantle, Nick
    Jourdan, Sophie
    DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1758 - 1759
  • [22] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Maffeis, Claudio
    Rabbone, Ivana
    PEDIATRIC DRUGS, 2022, 24 (05) : 499 - 512
  • [23] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Claudio Maffeis
    Ivana Rabbone
    Pediatric Drugs, 2022, 24 : 499 - 512
  • [24] Comparative effectiveness of insulin glargine 300 U/mL and insulin degludec 100 U/mL in insulin naive type 2 diabetes adults: the Restore-2 naive cohort
    Fadini, G. P.
    Buzzetti, R.
    Larosa, M.
    Rossi, M. C.
    Nicolucci, A.
    Cucinotta, D.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 74 - 74
  • [25] Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes
    Paola, Lucidi
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    DIABETES, 2020, 69
  • [26] A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus
    Woo, Vincent C.
    CLINICAL THERAPEUTICS, 2017, 39 (08) : S12 - S33
  • [27] Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats
    Saini, N. K.
    Wasik, B.
    Pires, J.
    Leale, D. M.
    Quach, N.
    Culp, W. T. N.
    Samms, R. J.
    Johnson, A. E.
    Owens, J. G.
    Gilor, C.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2021, 75
  • [28] Lower hypoglycaemia rates with insulin glargine 300 U/ml vs insulin degludec 100 U/ml in insulin-naive adults with type 2 diabetes: the BRIGHT randomised trial
    Bolli, G. B.
    Cheng, A.
    Bosnyak, Z.
    Boelle-Le Corfec, E.
    Cali, A. M. G.
    Wang, X.
    Frias, J.
    Roussel, R.
    Rosenstock, J.
    DIABETOLOGIA, 2018, 61 : S442 - S442
  • [29] BUDGET IMPACT MODEL FOR INSULIN GLARGINE-300U/ ML (GLA-300) VS INSULIN DEGLUDEC 100 U/ML IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS BASED ON THE INRANGE STUDY
    Safia, M.
    Hachelaf, Z.
    Aissaoui, A.
    Mahieu, A.
    Jabbar, O. A. Abdul
    VALUE IN HEALTH, 2024, 27 (12)
  • [30] Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus
    Blair, Hannah A.
    Keating, Gillian M.
    DRUGS, 2016, 76 (03) : 363 - 374
12345